ĚěĂŔ´ŤĂ˝

Feature Channels: Cell Biology

Filters close
Go to Advanced Search
Newswise: 2585_6308ea26451a0_31aoxkzbei_actual.rev.1661528614.jpg
Released: 2-Apr-2025 10:50 AM EDT
Study Reveals New Details on How Virus Builds Protective Shell
Indiana University

A research team at Indiana University Bloomington has uncovered new details about how a tiny virus builds its protective outer shell —a crucial part of its ability to infect cells.

Newswise: Stiffness Measurement Without Organoid Damage AIDS Drug Development for Fatty Liver Disease
Released: 2-Apr-2025 12:00 AM EDT
Stiffness Measurement Without Organoid Damage AIDS Drug Development for Fatty Liver Disease
National Research Council of Science and Technology

The research team led by Dr. Hyunwoo Kim and Dr. Myungae Bae at the Korea Research Institute of Chemical Technology (KRICT) has developed the nano-probe-based quantitative stiffness measurement technique for a non-alcoholic fatty liver disease (NAFLD) simulate artificial organoid model while minimizing tissue damage.

Released: 1-Apr-2025 8:10 PM EDT
Researcher Uncovers How Dietary Fat May Fuel Cancer Growth
Rutgers University-New Brunswick

A Rutgers biochemistry professor explains how omega-6 fatty acids found in Western diets can activate cellular growth pathways in certain breast cancers.

Newswise: Delicate Balancing Act Determines How Many Genome Gateways Form in Cells
Released: 31-Mar-2025 11:00 AM EDT
Delicate Balancing Act Determines How Many Genome Gateways Form in Cells
Sanford Burnham Prebys

As warehouses go, nuclei are more like libraries than bank vaults. Too many cellular components need access to the genome to lock it down like Fort Knox. Instead, large groupings of more than 1,000 individual protein molecules called nuclear pore complexes (NPCs) pepper the dividing membrane, serving as gateways for materials and messages entering and exiting the nucleus.

Not for public release

This news release is embargoed until 31-Mar-2025 8:00 AM EDT Released to reporters: 31-Mar-2025 8:00 AM EDT

A reporter's PressPass is required to access this story until the embargo expires on 31-Mar-2025 8:00 AM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Newswise: WHOI’s Mark Hahn named AAAS Fellow
Released: 27-Mar-2025 8:00 AM EDT
WHOI’s Mark Hahn named AAAS Fellow
Woods Hole Oceanographic Institution

AAAS welcomes 471 scientists and engineers in the class of 2024

Newswise: 002.jpg?itok=KSTPgLNp
Released: 26-Mar-2025 8:10 PM EDT
Nebraska Undergrads Uncover Ancient Secrets of Human Immunity
University of Nebraska-Lincoln

Nebraska undergrads uncover ancient secrets of human immunity

Released: 25-Mar-2025 12:00 PM EDT
New Software Finds Aging Cells That Contribute to Disease and Health Risks
University of Illinois Chicago

For human health, prematurely aging cells are a big problem. When a cell ages and stops growing, its function changes, which can cause or worsen cardiovascular disease, Alzheimer’s disease and other chronic diseases. But these cells are also like needles in a haystack, difficult to identify by traditional scientific measures.

Newswise: New S$130 Million National Research Initiative to Enhance Singapore’s Strategic Research Capabilities in RNA Biology and Its Applications
Released: 24-Mar-2025 7:40 AM EDT
New S$130 Million National Research Initiative to Enhance Singapore’s Strategic Research Capabilities in RNA Biology and Its Applications
National University of Singapore (NUS)

A new national programme that aims to position Singapore at the forefront of advancements in RNA science and applications was officially launched today. This new initiative – named National Initiative for RNA Biology and Its Applications (NIRBA) – is supported by the National Research Foundation (NRF) with total funding of S$130 million (US$97 million) over seven years. NIRBA will engage scientists and clinicians from leading institutions like the National University of Singapore (NUS), Nanyang Technological University, Singapore (NTU Singapore), Agency for Science, Technology and Research (A*STAR), and Duke-NUS Medical School.

Released: 21-Mar-2025 6:25 PM EDT
Peacekeeper Cells Protect the Body From Autoimmunity During Infection
University of Chicago Medical Center

New research from the University of Chicago shows how a specially trained population of immune cells keeps the peace by preventing other immune cells from attacking their own.

Newswise: New Study Sheds Light on How Bacteria ‘Vaccinate’ Themselves with Genetic Material from Dormant Viruses
Released: 21-Mar-2025 5:45 PM EDT
New Study Sheds Light on How Bacteria ‘Vaccinate’ Themselves with Genetic Material from Dormant Viruses
Johns Hopkins Medicine

Johns Hopkins Medicine scientists say they have shed new light on how bacteria protect themselves from certain phage invaders — by seizing genetic material from weakened, dormant phages and using it to “vaccinate” themselves to elicit an immune response.

Newswise: Scientists Witness Living Plant Cells Generate Cellulose and Form Cell Walls For the First Time
Released: 21-Mar-2025 2:00 PM EDT
Scientists Witness Living Plant Cells Generate Cellulose and Form Cell Walls For the First Time
Rutgers University-New Brunswick

In a groundbreaking study on the synthesis of cellulose – a major constituent of all plant cell walls – a team of Rutgers University-New Brunswick researchers has captured images of the microscopic process of cell-wall building continuously over 24 hours with living plant cells, providing critical insights that may lead to the development of more robust plants for increased food and lower-cost biofuels production.

Newswise: Scientists Demonstrate Pre-clinical Proof of Concept for Next-Gen DNA Delivery Technology
Released: 21-Mar-2025 11:05 AM EDT
Scientists Demonstrate Pre-clinical Proof of Concept for Next-Gen DNA Delivery Technology
Wistar Institute

Wistar Institute scientists and collaborators describe a next-generation vaccination technology that combines plasmid DNA with a lipid nanoparticle delivery system.

Newswise: Boosting Brain’s Waste Removal System Improves Memory in Old Mice
Released: 21-Mar-2025 11:00 AM EDT
Boosting Brain’s Waste Removal System Improves Memory in Old Mice
Washington University in St. Louis

Aging compromises the lymphatic vessels surrounding the brain, disabling waste drainage from the brain and impacting cognitive function. Researchers at WashU Medicine boosted lymphatic vessel integrity in old mice and found improvements in their memory compared with old mice without rejuvenated lymphatic vessels.

Released: 20-Mar-2025 9:00 AM EDT
Potential Targeted Therapy for Pediatric Brain Cancer Identified by Dana-Farber Team
Dana-Farber Cancer Institute

An international team of clinical collaborators, led by physician scientists from Dana-Farber Cancer Institute, performed a first-ever clinical test of the targeted therapy avapritinib in pediatric and young patients with a form of high-grade glioma. They found that the drug, already FDA-approved for certain adult cancers, was generally safe and resulted in tumor reduction visible on brain scans, as well as clinical improvement, in 3 out of 7 patients.

Newswise: Removing a Protein ‘Signal Jammer’ Improves Immunotherapy
Released: 19-Mar-2025 7:55 PM EDT
Removing a Protein ‘Signal Jammer’ Improves Immunotherapy
St. Jude Children's Research Hospital

Find how a mitochondrial protein protects cancer cells from immunotherapy, giving scientists a new target type to improve solid tumor treatment & save lives.

Newswise: Rutgers Launches Center to Tackle Barriers to Weight Loss and Other Causes of Disease
Released: 18-Mar-2025 6:30 PM EDT
Rutgers Launches Center to Tackle Barriers to Weight Loss and Other Causes of Disease
Rutgers Robert Wood Johnson Medical School

Rutgers Launches Center to Tackle Barriers to Weight Loss and Other Causes of Disease

Newswise: New Study Reveals Key Protein's Role in Spinal Disc Degeneration
Released: 17-Mar-2025 9:45 AM EDT
New Study Reveals Key Protein's Role in Spinal Disc Degeneration
Chinese Academy of Sciences

A recent study has unveiled the pivotal role of Ferroptosis Suppressor Protein 1 (FSP1) in intervertebral disc degeneration (IDD), a primary cause of chronic lower back pain. Researchers discovered that FSP1, when upregulated by the inflammatory cytokine TNFÎą, accelerates disc degeneration through caspase 3-dependent apoptosis and mitochondrial damage. This finding positions FSP1 as a promising therapeutic target for IDD, potentially offering relief to millions suffering from persistent back pain.

Newswise: New Genetic Insights Into Hypospadias: MAFB and CEBPA’s Role in Urothelial Growth
Released: 17-Mar-2025 9:10 AM EDT
New Genetic Insights Into Hypospadias: MAFB and CEBPA’s Role in Urothelial Growth
Chinese Academy of Sciences

A recent study has unveiled the critical roles of two transcription factors, MAFB and CEBPA, in the development of hypospadias, a common congenital malformation affecting male urethral development. The research reveals that MAFB and CCAAT/enhancer-binding protein alpha (CEBPA) regulate urothelial cell growth via the Wnt/β-catenin signaling pathway, offering new insights into the genetic mechanisms underlying this condition. These findings pave the way for innovative therapeutic strategies and a deeper understanding of the genetic and molecular foundations of hypospadias.

Newswise: Using Nanotech as a Way of Differentiating Cells From One Another
Released: 13-Mar-2025 8:40 PM EDT
Using Nanotech as a Way of Differentiating Cells From One Another
University of Rhode Island

Early diagnosis is crucial in disease prevention and treatment. Many diseases can be identified not just through physical signs and symptoms but also through changes at the cellular and molecular levels. When it comes to a majority of chronic conditions early detection, particularly at the cellular level, gives patients a better chance for successful treatment.



close
3.71808